Many patients with paroxysmal nocturnal hemoglobinuria have persistent anemia despite anti-C5
treatment. The efficacy and safety of the complement inhibitor iptacopan in PNH are unclear.

Research findings are summarized in a new Quick Take video.

To see the full article, follow this link: https://nej.md/48QKlcU

#hematology #oncology #clinicaltrials #medicalresearch #nejm